NASDAQ:CUTR Cutera - CUTR Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cutera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $36.23 +0.03 (+0.08%) (As of 02/3/2023 12:00 AM ET) Add Compare Share Share Today's Range$35.53▼$36.9450-Day Range$27.79▼$51.6552-Week Range$26.51▼$74.38Volume310,456 shsAverage Volume739,284 shsMarket Capitalization$710.47 millionP/E RatioN/ADividend YieldN/APrice Target$56.20 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Cutera MarketRank™ ForecastAnalyst RatingModerate Buy2.60 Rating ScoreUpside/Downside55.1% Upside$56.20 Price TargetShort InterestBearish23.20% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.44Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.47) to ($0.71) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.69 out of 5 starsComputer And Technology Sector486th out of 610 stocksElectromedical Equipment Industry21st out of 24 stocks 3.3 Analyst's Opinion Consensus RatingCutera has received a consensus rating of Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $56.20, Cutera has a forecasted upside of 55.1% from its current price of $36.23.Amount of Analyst CoverageCutera has only been the subject of 4 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted23.20% of the outstanding shares of Cutera have been sold short.Short Interest Ratio / Days to CoverCutera has a short interest ratio ("days to cover") of 9.7.Change versus previous monthShort interest in Cutera has recently increased by 2.25%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldCutera does not currently pay a dividend.Dividend GrowthCutera does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CUTR. Previous Next 3.0 News and Social Media Coverage News SentimentCutera has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Cutera this week, compared to 2 articles on an average week.Search Interest1 people have searched for CUTR on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Cutera to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cutera insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.10% of the stock of Cutera is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cutera are expected to grow in the coming year, from ($2.47) to ($0.71) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cutera is -8.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cutera is -8.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCutera has a P/B Ratio of 11.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Cutera (NASDAQ:CUTR) StockCutera, Inc. engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo. The company was founded by David A. Gollnick in August 1998 and is headquartered in Brisbane, CA.Read More Receive CUTR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter. Email Address CUTR Stock News HeadlinesFebruary 5, 2023 | americanbankingnews.comCutera, Inc. (NASDAQ:CUTR) Given Average Recommendation of "Hold" by BrokeragesFebruary 2, 2023 | americanbankingnews.comCutera (NASDAQ:CUTR) Now Covered by William BlairFebruary 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.January 17, 2023 | finance.yahoo.comStrong week for Cutera (NASDAQ:CUTR) shareholders doesn't alleviate pain of five-year lossJanuary 16, 2023 | finance.yahoo.comStrength Seen in Cutera (CUTR): Can Its 12.5% Jump Turn into More Strength?December 13, 2022 | finance.yahoo.comCutera's Charts Are Poised for an Upside BreakoutDecember 8, 2022 | finance.yahoo.comCutera, Inc. Announces Pricing of Offering of $100 Million of Convertible Senior NotesDecember 7, 2022 | finance.yahoo.comCutera, Inc. Announces Proposed Private Offering of $100 Million of Convertible Senior NotesFebruary 5, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.December 7, 2022 | finance.yahoo.comWith stock up 15%, Insiders of Cutera, Inc. (NASDAQ:CUTR) must be wishing they had bought more last yearDecember 2, 2022 | seekingalpha.comCutera: AviClear Key Differentiator, Reaffirm BuyNovember 21, 2022 | finance.yahoo.comCutera, Inc. to Participate in a Fireside Chat at the 34th Annual Piper Sandler Healthcare ConferenceNovember 10, 2022 | finance.yahoo.comCutera, Inc. to Participate in a Fireside Chat at the Stifel Healthcare 2022 ConferenceNovember 10, 2022 | finance.yahoo.comCutera, Inc. to Participate in a Fireside Chat at the Stephens Annual Investment ConferenceNovember 8, 2022 | finance.yahoo.comCutera Third Quarter 2022 Earnings: EPS Misses ExpectationsNovember 7, 2022 | finance.yahoo.comAviClear™ Now Broadly Available to US Physicians and Practitioners Upon National LaunchNovember 5, 2022 | seekingalpha.comCutera surges 12% as FY22 revenue outlook maintained despite forex impactNovember 4, 2022 | finance.yahoo.comCutera Announces Third Quarter 2022 Financial ResultsNovember 4, 2022 | finance.yahoo.comCutera (CUTR) Reports Q3 Loss, Tops Revenue EstimatesOctober 25, 2022 | finance.yahoo.comCutera’s AviClearTM 12-Month Clinical Data Presented at the 42nd Annual Fall Clinical Dermatology ConferenceOctober 17, 2022 | nasdaq.comZacks Industry Outlook Highlights IPG Photonics and Cutera - NasdaqOctober 13, 2022 | nasdaq.comImplied SPTM Analyst Target Price: $58 - NasdaqOctober 12, 2022 | benzinga.comMedical Laser Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | DataM - BenzingaOctober 3, 2022 | businesswire.comGlobal Hair Removal Market to Reach $1.2 Billion by 2027 at a CAGR of 10.44% - ResearchAndMarkets.com - Business WireSeptember 30, 2022 | businesswire.comGlobal Laser Hair Removal Market Report 2022: Conventional and Technological Advancement in Aesthetic Lasers Treatment Drives Growth - ResearchAndMarkets.com - Business WireSeptember 30, 2022 | globenewswire.com$11+ Billion Dermatology Devices Market Size to Grow at 11.2% CAGR, Globally, by 2028 - Growing Prevalence of Skin Cancers and Skin Disorders - GlobeNewswireSeptember 26, 2022 | businesswire.comGlobal Acne Treatment Market Report to 2027 - Featuring Galderma, Lumenis, Cutera and Alma Lasers Among Others - ResearchAndMarkets.com - Business WireSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CUTR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cutera and its competitors with MarketBeat's FREE daily newsletter. Email Address CUTR Company Calendar Last Earnings11/03/2021Today2/05/2023Next Earnings (Confirmed)2/28/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:CUTR CUSIPN/A CIK1162461 Webwww.cutera.com Phone(415) 657-5500Fax415-330-2444Employees461Year Founded1998Price Target and Rating Average Stock Price Forecast$56.20 High Stock Price Forecast$70.00 Low Stock Price Forecast$33.00 Forecasted Upside/Downside+55.1%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($4.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$2.06 million Net Margins-31.31% Pretax Margin-30.77% Return on Equity-225.70% Return on Assets-22.44% Debt Debt-to-Equity Ratio19.38 Current Ratio3.73 Quick Ratio3.16 Sales & Book Value Annual Sales$231.27 million Price / Sales3.07 Cash Flow$0.33 per share Price / Cash Flow108.92 Book Value$3.15 per share Price / Book11.50Miscellaneous Outstanding Shares19,610,000Free Float19,203,000Market Cap$710.47 million OptionableOptionable Beta1.58 Social Links Key ExecutivesDavid H. MowryChief Executive Officer & DirectorRohan SethChief Financial OfficerMichael KaravitisChief Technology Officer & Executive VPCharles Guy ThierChief Information OfficerJeremy LivianuSecretary, Vice President & General CounselKey CompetitorsACM ResearchNASDAQ:ACMRNano DimensionNASDAQ:NNDMCass Information SystemsNASDAQ:CASSAnterixNASDAQ:ATEXNavitas SemiconductorNASDAQ:NVTSView All CompetitorsInsiders & InstitutionsEmerald Advisers LLCSold 140,651 shares on 2/3/2023Ownership: 1.719%Emerald Mutual Fund Advisers TrustSold 120,278 shares on 2/3/2023Ownership: 1.352%Essex Investment Management Co. LLCBought 11,551 shares on 2/3/2023Ownership: 0.816%SG Americas Securities LLCBought 2,529 shares on 2/2/2023Ownership: 0.013%Zurcher Kantonalbank Zurich Cantonalbank Bought 789 shares on 2/1/2023Ownership: 0.016%View All Insider TransactionsView All Institutional Transactions CUTR Stock - Frequently Asked Questions Should I buy or sell Cutera stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last twelve months. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CUTR shares. View CUTR analyst ratings or view top-rated stocks. What is Cutera's stock price forecast for 2023? 5 brokerages have issued 12 month target prices for Cutera's stock. Their CUTR share price forecasts range from $33.00 to $70.00. On average, they expect the company's share price to reach $56.20 in the next twelve months. This suggests a possible upside of 55.1% from the stock's current price. View analysts price targets for CUTR or view top-rated stocks among Wall Street analysts. How have CUTR shares performed in 2023? Cutera's stock was trading at $44.22 at the start of the year. Since then, CUTR stock has decreased by 18.1% and is now trading at $36.23. View the best growth stocks for 2023 here. When is Cutera's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023. View our CUTR earnings forecast. How can I listen to Cutera's earnings call? Cutera will be holding an earnings conference call on Tuesday, February 28th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were Cutera's earnings last quarter? Cutera, Inc. (NASDAQ:CUTR) issued its earnings results on Wednesday, November, 3rd. The medical device company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by $0.11. The medical device company earned $57.38 million during the quarter, compared to the consensus estimate of $50.90 million. Cutera had a negative net margin of 31.31% and a negative trailing twelve-month return on equity of 225.70%. During the same quarter last year, the firm earned ($0.13) earnings per share. What guidance has Cutera issued on next quarter's earnings? Cutera updated its FY 2022 earnings guidance on Monday, January, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $252.00 million-$253.00 million, compared to the consensus revenue estimate of $259.00 million. What is David H. Mowry's approval rating as Cutera's CEO? 1 employees have rated Cutera Chief Executive Officer David H. Mowry on Glassdoor.com. David H. Mowry has an approval rating of 100% among the company's employees. This puts David H. Mowry in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Cutera own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include NVIDIA (NVDA), QUALCOMM (QCOM), AbbVie (ABBV), Micron Technology (MU), Gilead Sciences (GILD), Alibaba Group (BABA), DocuSign (DOCU), Pfizer (PFE), Block (SQ) and Twilio (TWLO). What is Cutera's stock symbol? Cutera trades on the NASDAQ under the ticker symbol "CUTR." Who are Cutera's major shareholders? Cutera's stock is owned by many different retail and institutional investors. Top institutional shareholders include Emerald Advisers LLC (1.72%), Emerald Mutual Fund Advisers Trust (1.35%), Essex Investment Management Co. LLC (0.82%), Rice Hall James & Associates LLC (0.39%), Legato Capital Management LLC (0.21%) and Greenwood Capital Associates LLC (0.15%). Insiders that own company stock include David H Mowry, J Daniel Plants, Joseph E Whitters, Katherine S Zanotti, Rohan Seth and Timothy J Oshea. View institutional ownership trends. How do I buy shares of Cutera? Shares of CUTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cutera's stock price today? One share of CUTR stock can currently be purchased for approximately $36.23. How much money does Cutera make? Cutera (NASDAQ:CUTR) has a market capitalization of $710.47 million and generates $231.27 million in revenue each year. The medical device company earns $2.06 million in net income (profit) each year or ($4.21) on an earnings per share basis. How many employees does Cutera have? The company employs 461 workers across the globe. How can I contact Cutera? Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The official website for the company is www.cutera.com. The medical device company can be reached via phone at (415) 657-5500, via email at ir@cutera.com, or via fax at 415-330-2444. This page (NASDAQ:CUTR) was last updated on 2/5/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.